HOLDEN LOWELL THOMAS (CFO) purchased 1.6% of their position (130K shares) of NASCENT BIOTECH INC. on the open market
Open‑market purchase worth $5.2K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/9/2023ACC: 0001477932-23-004429
DirectorOfficer· CFO
+711K
Net shares
Net buyer
$40.1K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
711K acquired
Non-Derivative Transactions2
Common stock
Direct
Shares
+581K
Price / share
$0.06
Trade value
$34.86K
% of position
7.5%
—
7.70M→8.28M
Common stock
Direct
Shares
+130K
Price / share
$0.04
Trade value
$5.20K
% of position
1.6%
—
8.28M→8.41M
Total
Net shares
+711K
Net value
$40.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | — | J · J | +581K | $0.06 | $34.86K | 7.5% | 7.70M | 8.28M |
| Common stock Direct | — | P · Purchase | +130K | $0.04 | $5.20K | 1.6% | 8.28M | 8.41M |
| Total | +711K | $40.06K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported